We are live on ! Find out more
BLTE

Belite Bio
BLTE

6 hedge funds and large institutions have $2.15M invested in Belite Bio in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.29% more ownership

Funds ownership: 0% → 0.29% (+0.29%)

Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AWS
Atria Wealth Solutions
New York
+$927K
2
Millennium Management
Millennium Management
New York
+$169K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$124K
4
BAMF
BI Asset Management Fondsmaeglerselskab
Denmark
+$55.4K
5
UBS Group
UBS Group
Switzerland
+$12.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AWS
1
Atria Wealth Solutions
New York
$1.54M +$927K +49,463 New
Millennium Management
2
Millennium Management
New York
$280K +$169K +8,995 New
Qube Research & Technologies (QRT)
3
Qube Research & Technologies (QRT)
United Kingdom
$207K +$124K +6,640 New
BAMF
4
BI Asset Management Fondsmaeglerselskab
Denmark
$92K +$55.4K +2,954 New
UBS Group
5
UBS Group
Switzerland
$21K +$12.8K +683 New
PWMG
6
Prestige Wealth Management Group
New Jersey
$6K +$3.75K +200 New

BLTE Hedge Fund Activity: Q2 2022 in Review

6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q2 2022, worth a combined $2.15M.

Buyers outnumbered sellers: 6 funds opened new BLTE positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Atria Wealth Solutions, opening a new position worth an estimated $927K.

  • 6 institutional investors held Belite Bio (BLTE) as of Q2 2022, up from 0 in Q1 2022.
  • Funds reported $2.15M of Belite Bio stock for Q2 2022.
  • 6 funds opened new Belite Bio positions in Q2 2022 and 0 closed out, a net change of +6 holders.
  • The largest Belite Bio buyer in Q2 2022 was Atria Wealth Solutions, an estimated $927K added.

Based on aggregated 13F filings for Q2 2022.